ĚěĂŔ´ŤĂ˝

Feature Channels: Biotech

Filters close
Newswise: New Implant Will Help Patients Regenerate Their Own Heart Valves
Released: 11-Feb-2025 9:15 PM EST
New Implant Will Help Patients Regenerate Their Own Heart Valves
Georgia Institute of Technology

A 3D-printed, bioresorbable heart valve promotes tissue regeneration, potentially eliminating the need for repeated surgeries for adult and pediatric heart patients.

Newswise: MSU Expert: Using Light to Hear Biology
Released: 11-Feb-2025 8:50 PM EST
MSU Expert: Using Light to Hear Biology
Michigan State University

MSU expert: Using light to hear biology

Not for public release

This news release is embargoed until 17-Feb-2025 5:00 PM EST Released to reporters: 11-Feb-2025 8:45 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 17-Feb-2025 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 11-Feb-2025 8:40 PM EST
‘Junk’ RNA segments play role in protein production, cell stress response
Ohio State University

Scientists have discovered that some tiny segments of RNA thought to be junk instead have a functional role in suppressing production of certain messenger RNAs and appear to help cells respond to oxidative stress.

Released: 11-Feb-2025 8:20 PM EST
Cancer Research Institute Announces Fall 2024 CRI Irvington and Immuno-Informatics Fellows Advancing Cancer Immunotherapy
Cancer Research Institute

The Cancer Research Institute (CRI) proudly welcomes its Fall 2024 class of CRI Irvington Postdoctoral Fellows and Immuno-Informatics Fellows—exceptional scientists pioneering breakthroughs in immuno-oncology. From CAR T-cell therapy to computational immunology, these researchers are shaping the future of cancer treatment by harnessing the power of the immune system.

Newswise: Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium
Released: 11-Feb-2025 7:55 PM EST
Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) Cancers Symposium, on February 13-15, 2025. The Dana-Farber led research exemplifies innovative and multidisciplinary expertise in prostate, kidney, and bladder cancers, and includes studies examining novel treatments and predictive biomarkers.

access_time Embargo lifts in 2 days
This news release is embargoed until 17-Feb-2025 3:00 PM EST Released to reporters: 11-Feb-2025 6:50 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 17-Feb-2025 3:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Feb-2025 11:00 AM EST Released to reporters: 11-Feb-2025 5:45 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 12-Feb-2025 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Unlocking the Secrets of Tea Quality: New Insights Into Theanine Regulation
Released: 11-Feb-2025 9:40 AM EST
Unlocking the Secrets of Tea Quality: New Insights Into Theanine Regulation
Chinese Academy of Sciences

A new study has unveiled the intricate genetic mechanisms that regulate theanine accumulation in tea plants—a key determinant of tea quality. Scientists have identified CsMYB73, a crucial transcription factor that orchestrates the balance between theanine synthesis and degradation by controlling two key enzymes, CsGGT2 and CsGGT4. The study reveals that CsMYB73 negatively regulates theanine levels by activating theanine-degrading enzyme CsGGT2 while suppressing CsGGT4, which facilitates theanine synthesis. These findings not only deepen our understanding of the metabolic intricacies of tea plants but also provide a genetic roadmap for optimizing tea quality through targeted breeding and biotechnological approaches.

Newswise: From Sour to Sweet: The Genetic Pathway of Jujube Domestication
Released: 11-Feb-2025 9:25 AM EST
From Sour to Sweet: The Genetic Pathway of Jujube Domestication
Chinese Academy of Sciences

A new study has unveiled the genetic mechanism controlling citric acid content in jujube fruit, identifying a natural mutation in the promoter of the ZjACO3 gene. This mutation is strongly associated with fruit acidity levels, offering crucial insights into the domestication process of jujube from its wild, sour ancestor to the cultivated, sweeter varieties.

Newswise: Smart Orchards Get Smarter: New AI Method for Fruit Labeling
Released: 11-Feb-2025 9:05 AM EST
Smart Orchards Get Smarter: New AI Method for Fruit Labeling
Chinese Academy of Sciences

A cutting-edge AI method, EasyDAM_V4, is set to transform fruit detection in agriculture by enabling automatic labeling of fruit datasets with unprecedented adaptability across species. This breakthrough is crucial for the development of smart orchards, where high-precision fruit detection is the backbone of applications like yield prediction, automated harvesting, and phenotypic analysis.

Newswise: Memorial Sloan Kettering Cancer Center Surgeon-Scientist, Vinod Balachandran, MD, Named to The Washington Post Next 50
Released: 11-Feb-2025 8:25 AM EST
Memorial Sloan Kettering Cancer Center Surgeon-Scientist, Vinod Balachandran, MD, Named to The Washington Post Next 50
Memorial Sloan Kettering Cancer Center

Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at Memorial Sloan Kettering Cancer Center, has been named to the inaugural edition of the Post Next 50, a list of up-and-coming changemakers shaping society in 2025.

Newswise: Discovering the Genetic Puzzle Behind Variegated Leaves
Released: 11-Feb-2025 8:15 AM EST
Discovering the Genetic Puzzle Behind Variegated Leaves
Chinese Academy of Sciences

A new study has uncovered a previously unknown plastome structural variation in the variegated plant Dianella tasmanica, providing a genetic explanation for its distinctive leaf coloration. Researchers identified an 11-base-pair (bp) inverted repeat that triggers a dramatic plastome rearrangement, resulting in the largest inverted repeat and the smallest large single-copy region ever recorded in land plants.

Newswise: Grapevine Anthocyanins: How Drought Stress Triggers Colorful Adaptations
Released: 11-Feb-2025 7:40 AM EST
Grapevine Anthocyanins: How Drought Stress Triggers Colorful Adaptations
Chinese Academy of Sciences

New research has uncovered a surprising silver lining to drought conditions—enhancing the color and quality of grapes by increasing anthocyanin levels through a finely tuned molecular pathway. Scientists have identified how drought stress activates the ABA signaling pathway, triggering the microRNA miR156b. This microRNA, in turn, suppresses specific inhibitors (VvSBP8 and VvSBP13) of anthocyanin production, effectively removing roadblocks to pigment accumulation. With these barriers lifted, the MBW complex—a key regulator of anthocyanin biosynthesis—forms more efficiently, leading to richer, deeper hues in grape berries. This discovery not only advances our understanding of grapevine resilience but also offers practical strategies for improving grape quality in drought-prone regions, presenting significant opportunities for the global wine industry.

Released: 11-Feb-2025 2:10 AM EST
Frontier Scientific Solutions Announces Full-Scale Construction of Largest GMP Temperature-Controlled Facility for Life Sciences in North America at Wilmington International Airport
Frontier Scientific Solutions

Frontier Scientific Solutions is excited to announce that construction of its state-of-the-art cGMP temperature-controlled facilities at Wilmington International Airport (ILM) is in full swing with the first vertical structures being installed. This groundbreaking project is set to become the largest GMP temperature-controlled facility fully dedicated to the life sciences sector in North America, further solidifying Wilmington's position as a critical hub for the global life sciences supply chain.

Newswise: Eating Gradually Increasing Doses of Store-Bought Peanut Butter Enables Children With High-Threshold Allergy to Safely Consume Peanuts
7-Feb-2025 7:40 PM EST
Eating Gradually Increasing Doses of Store-Bought Peanut Butter Enables Children With High-Threshold Allergy to Safely Consume Peanuts
Mount Sinai Health System

Findings suggest a safe, inexpensive, and effective pathway for allergists to treat children who already tolerate at least half a peanut

Newswise: Tackling the Threat of Drug-Resistant E. Coli in China
Released: 10-Feb-2025 9:15 AM EST
Tackling the Threat of Drug-Resistant E. Coli in China
Chinese Academy of Sciences

A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) among diarrheagenic Escherichia coli (E. coli), a major foodborne pathogen. Analyzing 9,068 isolates from sporadic human diarrhea cases, the research paints a troubling picture: the majority of isolates are resistant to at least one antimicrobial agent, with many demonstrating multidrug resistance. These findings are critical for shaping clinical antibiotic treatment strategies and prioritizing efforts to curb the spread of resistance.

Released: 10-Feb-2025 8:10 AM EST
Age and Gender Impacts Effectiveness of New Gene Therapy Treatments for Eye Diseases, New Study Finds
University of Bristol

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene therapy treatments and could cause damage to the eye.

Newswise: New Insights Into How Dairy Cattle Efficiently Convert Plant Biomass Into Nutrients: Unlocking the Power of Rumen Microbiota
Released: 10-Feb-2025 6:30 AM EST
New Insights Into How Dairy Cattle Efficiently Convert Plant Biomass Into Nutrients: Unlocking the Power of Rumen Microbiota
Chinese Academy of Sciences

A research team has identified key microbial genomes and enzymatic strategies responsible for breaking down the lignocellulosic biomass by employing over 240 rumen metagenome samples from Holstein cows.

Released: 7-Feb-2025 8:00 PM EST
Texas Tech Lab Plays Key Role in Potential New Pathway to Fight Viruses
Texas Tech University

Professor David Ray’s laboratory in the Department of Biological Sciences helped identify genetic components in bats that provide insight into their immune systems.



close
2.78105